GSK945237
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK945237, covering 2012-03-19 to 2015-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc. [Phase 1]